CEMAT Cemat A/S

No. 13/2025 - Interim report H1 2025

No. 13/2025 - Interim report H1 2025

Nasdaq Copenhagen

Nikolaj Plads 6

DK-1067 Copenhagen K   

Copenhagen, 27 August 2025

ANNOUNCEMENT no. 13/2025

 

 

 

 

 

 

 

INTERIM REPORT, H1 2025

The company has today published the Interim Report for H1 2025 (covering the period from 1 January 2025 to 30 June 2025). The Interim Report is attached to this company announcement and can be downloaded from the company’s website .

 

Cemat A/S

Jaroslaw Lipinski

CEO

This announcement has been prepared in a Danish-language and an English-language

version. In case of doubt, the Danish version prevails.

Attachments



EN
27/08/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cemat A/S

 PRESS RELEASE

Nr. 2/2026 - Årsrapport 2025

Nr. 2/2026 - Årsrapport 2025 Nasdaq Copenhagen                                                                                    Nikolaj Plads 6DK-1067 Copenhagen K    København, 25. februar 2026SELSKABSMEDDELELSE nr. 2/2026 OFFENTLIGGØRELSE AF ÅRSRAPPORT Hermed offentliggøres Cemat A/S’ årsrapport for 2025 med henblik på godkendelse på selskabets ordinære generalforsamling. Vær venligst opmærksom på, at Cemat A/S’ officielle årsrapport er udarbejdet efter ESEF-forordningen og vedhæftet i en zip fil og kan ligeledes fremfindes via link på Cemat A/S' hjemmeside. En uofficiel kopi af års...

 PRESS RELEASE

Nr. 2/2026 - Annual report 2025

Nr. 2/2026 - Annual report 2025 Nasdaq Copenhagen                                                                                    Nikolaj Plads 6DK-1067 Copenhagen K    Copenhagen, 25 February 2026ANNOUNCEMENT no. 2/2026 PUBLICATION OF ANNUAL REPORT The annual report for 2025 of Cemat A/S has now been published in advance of the expected approval at the company’s annual general meeting. Please note that Cemat A/S’ official annual report has been prepared in compliance with the ESEF Regulation and can be visited in the attached zip file and via the weblink on Cemat A/S’ website. An uno...

 PRESS RELEASE

Nr. 1/2026 - Finanskalender 2026/2027

Nr. 1/2026 - Finanskalender 2026/2027 Nasdaq Copenhagen                                                                                    Nikolaj Plads 6DK-1067 Copenhagen K    København, 20. februar 2026SELSKABSMEDDELELSE nr. 1/2026 FINANSKALENDER 2026/2027 Selskabets finanskalender for 2026/2027 er fastlagt som følger: 2026: 25.02.2026                     Årsrapport 2025 24.03.2026                     Ordinær generalforsamling 26.08.2026                     Delårsrapport, første halvår 2026 2027: 23.02.2027                     Årsrapport 2026 18.03.2027                     Ordi...

 PRESS RELEASE

No. 1/2026 - Financial calendar 2026/2027

No. 1/2026 - Financial calendar 2026/2027 Nasdaq Copenhagen                                                                                    Nikolaj Plads 6DK-1067 Copenhagen K    Copenhagen, 20 February 2026ANNOUNCEMENT no. 1/2026 FINANCIAL CALENDAR 2026/2027 The financial calendar for 2026/2027 has been scheduled as follows: 2026:                            25.02.2026 Annual Report 2025                            24.03.2026  Annual General Meeting 26.08.2026 Interim Report, H1 2026 2027: 23.02.2027 Annual Report 2026 18.03.2027  Annual General Meeting Cemat A/S  Frede C...

 PRESS RELEASE

No. 19/2025 - Major shareholders’ announcement

No. 19/2025 - Major shareholders’ announcement Nasdaq Copenhagen                                                                                    Nikolaj Plads 6DK-1067 Copenhagen K    Copenhagen, 9 September 2025ANNOUNCEMENT no. 19/2025 Major shareholders’ announcement Pursuant to Article 38 of the market abuse regulation Cemat A/S hereby announces that Frede Clausen has informed Cemat A/S that he owns 12,578,091 shares in Cemat A/S equivalent to 5.034 % of the share capital and the voting rights in the company. Cemat A/S Jaroslaw Pawel LipinskiCEO                       This ann...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch